Carotid endarterectomy within 2 weeks of minor ischemic stroke: A prospective study

Objective: Data front multicenter symptomatic trials have shown that benefit from carotid endarterectomy (CEA) was greatest in patients with carotid disease operated within 2 weeks of their last ischemic event. We prospectively analyzed the safety and benefit of CEA performed within 2 weeks of a stroke. Methods:The study involved patients with acute minor stroke admitted to two stroke units who underwent CEA within 2 weeks of their last ischemic event, once they were considered neurologically stable. Preoperative workup included scoring ischemia-related symptoms according to a modified ranking scale (mRS), carotid duplex scan, transcranial Doppler ultrasound, and head computed tomography or magnetic resonance imaging. All patients underwent neorological assessment on admission, 1 day before and 2 days after CEA, and at discharge. A complete neurological and ultrasound follow-tip was performed at 1, 6, and 12 months after CEA, then yearly. All procedures were eversion CEA Under deep general anesthesia, with selective shunting. Endpoints were perioperative (30-day) stroke/mortality rate or cerebral bleeding and long-term stroke recurrence or cerebral hemorrhage. Results: Between 2000 and 2005, 102 patients with a mRS <= 2 underwent CEA within a median 8 days of acute ischemic stroke. Shooting and contralateral carotid occlusion were found significantly correlated. There were no perioperative strokes or deaths, or cerebral hemorrhage. All patients were followed tip for a mean 34 months (range 1-66) with no recurrent stroke or cerebral bleeding. Conclusions: CEA can be performed within 2 weeks of carotid-related ischemic stroke with no perioperative stroke or cerebral bleeding, preventing the risk of stroke recurrence.